Camposomes™

Aphios is developing a nanosomal formulation of camptothecin, a potent and exciting anti-cancer agent. Water soluble derivatives of camptothecin, a unique topoisomerase 1 inhibitor, have recently been approved by the FDA for use in colorectal cancer. These derivatives may not be as stable or as effective as neat camptothecin derived from the Chinese tree, Camptotheca acuminata. To date, the National Cancer Institute of the NIH has conducted in vivo studies on Aphios' Camposomes™ product against lymphomas in nude mice with positive results.

For more information, contact Aphios.